Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Frontiers in Oncology
|
August 13, 2024
Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer
Sanat Kulkarni, Ketankumar Gajjar, Srinivasan Madhusudan
BJOG : an International Journal of Obstetrics and Gynaecology
|
March 25, 2026
Risk-Reducing Salpingectomy: An Emerging, Novel Ovarian Cancer Prevention Strategy
Ketankumar Gajjar, Annika Idahl, Annika Strandel, et al.
The Cochrane Database of Systematic Reviews
|
August 30, 2022
Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer
Shaun Hiu, Andrew Bryant, Ketankumar Gajjar, et al.
Archives of Gynecology and Obstetrics
|
March 1, 2023
A study of recurrence, complication and survival rates in patients with early stage vulval cancer undergoing sentinel lymph node sampling: a single-centre experience
Emmanouil Katsanevakis, Anuja Joshi, Zun Zhen Ong, et al.
American Journal of Therapeutics
|
September 1, 2022
Residual Disease After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 2: Network Meta-analysis Incorporating Expert Elicitation to Adjust for Publication Bias
Andrew Bryant, Michael Grayling, Ahmed Elattar, et al.
The Cochrane Database of Systematic Reviews
|
October 25, 2021
Interventions targeted at women to encourage the uptake of cervical screening
Helen Staley, Aslam Shiraz, Norman Shreeve, et al.
BMC Surgery
|
October 29, 2025
Beyond Pathology: A Procedure-Based Approach to Planning and Predicting Outcomes in Robotic Gynaecological Oncology Surgery
Mohamed Abdelwanis Mohamed Abdelaziz, Ayodele Olaleye, Khaled Sabrah, et al.
American Journal of Therapeutics
|
January 6, 2023
Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis
Andrew Bryant, Eugenie Johnson, Michael Grayling, et al.
BMJ Open
|
August 29, 2022
Residual disease after primary surgery for advanced epithelial ovarian cancer: expert elicitation exercise to explore opinions about potential impact of publication bias in a planned systematic review and meta-analysis
Andrew Bryant, Michael Grayling, Shaun Hiu, et al.
The Cochrane Database of Systematic Reviews
|
September 26, 2022
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery
Andrew Bryant, Shaun Hiu, Patience T Kunonga, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Frontiers in Oncology
|
August 13, 2024
Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer
Sanat Kulkarni, Ketankumar Gajjar, Srinivasan Madhusudan
BJOG : an International Journal of Obstetrics and Gynaecology
|
March 25, 2026
Risk-Reducing Salpingectomy: An Emerging, Novel Ovarian Cancer Prevention Strategy
Ketankumar Gajjar, Annika Idahl, Annika Strandel, et al.
The Cochrane Database of Systematic Reviews
|
August 30, 2022
Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer
Shaun Hiu, Andrew Bryant, Ketankumar Gajjar, et al.
Archives of Gynecology and Obstetrics
|
March 1, 2023
A study of recurrence, complication and survival rates in patients with early stage vulval cancer undergoing sentinel lymph node sampling: a single-centre experience
Emmanouil Katsanevakis, Anuja Joshi, Zun Zhen Ong, et al.
American Journal of Therapeutics
|
September 1, 2022
Residual Disease After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 2: Network Meta-analysis Incorporating Expert Elicitation to Adjust for Publication Bias
Andrew Bryant, Michael Grayling, Ahmed Elattar, et al.
The Cochrane Database of Systematic Reviews
|
October 25, 2021
Interventions targeted at women to encourage the uptake of cervical screening
Helen Staley, Aslam Shiraz, Norman Shreeve, et al.
BMC Surgery
|
October 29, 2025
Beyond Pathology: A Procedure-Based Approach to Planning and Predicting Outcomes in Robotic Gynaecological Oncology Surgery
Mohamed Abdelwanis Mohamed Abdelaziz, Ayodele Olaleye, Khaled Sabrah, et al.
American Journal of Therapeutics
|
January 6, 2023
Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis
Andrew Bryant, Eugenie Johnson, Michael Grayling, et al.
BMJ Open
|
August 29, 2022
Residual disease after primary surgery for advanced epithelial ovarian cancer: expert elicitation exercise to explore opinions about potential impact of publication bias in a planned systematic review and meta-analysis
Andrew Bryant, Michael Grayling, Shaun Hiu, et al.
The Cochrane Database of Systematic Reviews
|
September 26, 2022
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery
Andrew Bryant, Shaun Hiu, Patience T Kunonga, et al.
Page
of 2